REGULATION OF KIDNEY-SPECIFIC GENE EXPRESSION
肾脏特异性基因表达的调节
基本信息
- 批准号:2391431
- 负责人:
- 金额:$ 23.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-04-15 至 2000-03-31
- 项目状态:已结题
- 来源:
- 关键词:DNA footprinting gel mobility shift assay gene expression genetic library genetic mapping genetic promoter element genetic regulatory element genetically modified animals intermolecular interaction laboratory mouse membrane transport proteins molecular cloning nucleic acid sequence renal tubular transport saluresis tissue /cell culture transcription factor transfection
项目摘要
The long-term objectives of this project are to identify the cis-acting
regulatory elements and transcription factors that are responsible for
kidney-specific gene expression. The proposed studies will examine the
renal absorptive Na-K-Cl cotransporter (Nkcc2/Slc12a1) as a model kidney-
specific gene. In the kidney, NKCC2 mediates active reabsorption of NaCl
in the thick ascending limb of the loop of Henle and represents the site
of action of the clinically important loop diuretics furosemide and
bumetanide. Importantly, expression of Nkcc2 transcripts is only observed
in the kidney. Recent studies demonstrate that the Nkcc2 gene is under
transcriptional control and that the Nkcc2 promoter exhibits cell-lineage-
specific activity. The proposed studies will test the hypothesis that
kidney-specific transcription of Nkcc2 is mediated by the interaction
between kidney-enriched transcription factors and regulatory elements of
the Nkcc2 gene. To identify regulatory elements that are responsible for
kidney-specific promoter activity, fragments of the proximal 5' flanking
region of the Nkcc2 gene will be ligated to a promoterless reporter gene
and transiently expressed in cultured kidney cells. Evidence for cell-
type-specific promoter activity will be obtained by transfection into
cells of differing lineages. It will be important to verify that
regulatory elements identified in vitro also confer kidney-specificity
upon expression of a lacZ reporter gene in transgenic mice. Specific
enhancer and negative regulatory elements within the 5' flanking region
will be identified by deletion analysis and phylogenetic sequence
conservation. Regulatory elements located elsewhere in the gene will be
identified on the basis of DNase I hypersensitivity. Whether candidate
regions contain kidney-specific regulatory elements will be determined by
evaluating their effects on transcription from a heterologous promoter
both in vitro and in vivo. Electrophoretic mobility-shift assays will be
performed to determine whether cis-acting elements bind to kidney-enriched
nuclear proteins. Specific sites of DNA-protein interaction will be
defined using in vitro DNA footprinting, and the effects of mutations of
the elements on protein-binding and transcriptional activity will be
assessed. Transcription factors that bind to relevant regulatory elements
will be identified by Southwestern blotting or UV crosslinking, and cDNAs
encoding these proteins will be cloned by screening expression libraries
with recognition site probes. Identification of the cis-acting regulatory
elements that are required for transcription of Nkcc2 will provide general
insights into mechanisms of kidney-specific gene expression: will be
important for future studies of dysregulated expression of Nkcc2 in states
of abnormal renal salt handling, such as Bartter's syndrome and essential
hypertension; and will provide reagents that may be useful for future in
vivo gene therapy of the kidney. Characterization of the transcription
factors involved in expression of Nkcc2 may also be clinically important
since mutations affecting such proteins may cause developmental,
neoplastic, or cystic disorders of the kidney.
该项目的长期目标是确定顺式作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Igarashi其他文献
Peter Igarashi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Igarashi', 18)}}的其他基金
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
- 批准号:
7832043 - 财政年份:2009
- 资助金额:
$ 23.26万 - 项目类别:
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
- 批准号:
7936337 - 财政年份:2009
- 资助金额:
$ 23.26万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
7883980 - 财政年份:2009
- 资助金额:
$ 23.26万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
8148016 - 财政年份:2007
- 资助金额:
$ 23.26万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
8097975 - 财政年份:2007
- 资助金额:
$ 23.26万 - 项目类别:
UT southwestern O'Brien Kidney Research Core Center
德克萨斯大学西南奥布莱恩肾脏研究核心中心
- 批准号:
8912182 - 财政年份:2007
- 资助金额:
$ 23.26万 - 项目类别:














{{item.name}}会员




